Table 3 Baseline clinical characteristics and outcomes of primary retinal detachments by oil type
| Â | Total | Densiron | Silicone Oil | p Value |
|---|---|---|---|---|
Total | Â | 33 | 61 | - |
Age (years, IQR) | 62 (53 to 72) | 61 (55 to 74) | 62 (51 to 69) | 0.158 |
Gender (% Male) | 71 (75.5%) | 26 (78.8%) | 45 (73.8%) | 0.626 |
Laterality (% Right) | 48 (51.1%) | 17 (51.5%) | 31 (50.8%) | 1.000 |
High Myope (% Yes) | 6 (6.4%) | 3 (9.1%) | 3 (4.9%) | 0.662 |
Ocular Co-morbidities | 34 (36.2%) | 15 (45.5%) | 19 (31.1%) | 0.184 |
Preoperative Lens | Â | Â | Â | Â |
Phakic | 45 (57.7%) | 18 (60.0%) | 27 (56.3%) | 0.816 |
Pseudophakic | 33 (42.3%) | 12 (40.0%) | 21 (43.8%) | |
Macula Status | Â | Â | Â | Â |
Off | 67 (71.3%) | 23 (69.7%) | 44 (72.1%) | 0.815 |
On | 27 (28.7%) | 10 (30.3%) | 17 (27.9%) | |
Giant Retinal Tear | 6 (6.4%) | 0 (0.0%) | 6 (9.8%) | 0.087 |
PVR C | 13 (13.8%) | 3 (9.1%) | 10 (16.4%) | 0.532 |
Retinectomy | 3 (3.2%) | 0 (0.0%) | 3 (4.9%) | 0.549 |
Perfluorocarbon | 20 (21.3%) | 3 (9.1%) | 17 (27.9%) | 0.038 |
Combined Buckle/PPV | 5 (5.3%) | 0 (0.0%) | 5 (8.2%) | 0.158 |
Presentation to Surgery (days) | 2 (0 to 7) | 2 (0 to 7) | 2 (0 to 7) | 0.707 |
Postoperative Lens | Â | Â | Â | Â |
Phakic | 9 (9.6%) | 3 (9.1%) | 6 (9.8%) | 1.000 |
Pseudophakic | 85 (90.4%) | 30 (90.9%) | 55 (90.2%) | |
Duration of oil (days) | 147 (91 to 215) | 84 (68 to 124) | 186 (133 to 233) | < 0.001 |
Visual Loss | 15 (16.0%) | 2 (6.1%) | 13 (21.3%) | 0.076 |
Unexplained Visual Loss | 8 (8.5%) | 0 (0.0%) | 8 (13.1%) | 0.047 |